Skip navigation

Pfizer takes its shot at a vaccine for evasive superbug

CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.Full story

Intercell vaccine gets U.S. pediatric approval

VIENNA (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for pediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it had achieved in Europe in February. Full story

UK first in EU to get Merck's new Schmallenberg vaccine

LONDON (Reuters) - British farmers will be the first in Europe to get a vaccine against Schmallenberg virus, a new livestock disease that hit the continent in 2011. Full story

Sponsored Links

Articles

Wisconsin bill would ban mandatory flu shots

Measles surges in UK years after flawed research

Court: woman can seek lawyer fees in vaccine case

Newer whooping cough vaccine not as protective

WHO says single yellow fever shot is enough

Vaccine for the H7N9 Bird Flu: How Will We Know It Works?

Is your dog's Parvo vaccine effective?

India announces low-cost rotavirus vaccine

HPV-related cancers rose before vaccines hit market

News Summary: Vaccine project aids poor countries

Video

  UK measles outbreak could spread

A dramatic call to get all teenagers in Wales vaccinated against measles as an epidemic sweeps the region where thousands of children haven’t been vaccinated. ITV’s Emily Morgan reports

  More evidence that vaccines aren’t linked to autism

According to a new report in the Journal of Pediatrics, vaccines are not associated with an increased risk of developing autism. After analyzing records from more than 1000 children the researchers found no link between the amount of antigen exposure and later developing autism. NBC’s Dr. Nancy Snyd

  CDC: Flu vaccine often doesn’t work

In a new study out Thursday from the Centers for Disease Control, the vaccine proved effective just over half of the time. And among seniors who are 65 years old and older, one of the most vulnerable populations, the vaccine only offered nine percent protection. NBC’s Robert Bazell reports.

  Teen boys in Sydney get HPV vaccine

High school boys in Sydney, Australia, are the first males in the world to be vaccinated against cervical cancers caused by HPV, a virus males can transmit but not develop. NBCNews.com's Dara Brown reports.

  Gates: ‘How can innovation help those most in need?’

Bill Gates joins Morning Joe to discuss the importance of immunization all over the world and how his foundation is committed to getting vaccinations to those who need it. Gates also talks about the degree of difficulty of getting vaccinations to some areas but says, “technology can make these thing

advertisement | ad info

Related Photos

Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses in her lab at Pfizer headquarters in Pearl River
Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses in her lab at Pfizer headquarters in Pearl River

Kathrin Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses for a portrait in one of her labs at Pfizer headquarters in Pearl River, New York, April 19, 2013. Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cerv

A child receives polio vaccination drops during national vaccination campaign in Managua.
A child receives polio vaccination drops during national vaccination campaign in Managua.

A child receives polio vaccination drops during a national vaccination campaign in Managua April 15, 2013. Parents are expected to bring their children to thousands of vaccination posts from April 15 to 21, dedicated to the National Immunization Campaign, in order to raise the rate of immunization a

File photo of bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine during a vaccination programme in Schiedam
File photo of bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine during a vaccination programme in Schiedam

Bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine are seen lined up during a vaccination programme in Schiedam in this November 23, 2009 file picture. REUTERS/Jerry Lampen/Files